— Know what they know.
Not Investment Advice

PODD NASDAQ

Insulet Corporation
1W: +5.5% 1M: -19.0% 3M: -35.2% YTD: -44.6% 1Y: -52.1% 3Y: -51.0% 5Y: -32.5%
$154.87
-2.02 (-1.29%)
 
Weekly Expected Move ±10.3%
$117 $132 $147 $163 $178
NASDAQ · Healthcare · Medical - Devices · Alpha Radar Sell · Power 41 · $10.7B mcap · 69M float · 2.03% daily turnover · Short 32% of daily vol

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$2.7B +30.7% ▲
5Y CAGR: +24.5%
Gross Profit
$1.9B +34.2% ▲
5Y CAGR: +27.2%
Operating Income
$474M +53.4% ▲
5Y CAGR: +55.9%
Net Income
$247M -40.9% ▼
5Y CAGR: +105.2%
EPS (Diluted)
$3.48 -39.8% ▼
5Y CAGR: +103.4%
EBITDA
$587M +38.5% ▲
5Y CAGR: +39.7%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$1.1B$1.3B$1.7B$2.1B$2.7B
YoY Growth+21.5%+18.8%+30.0%+22.1%+30.7%
Cost of Revenue$347M$500M$537M$626M$768M
Gross Profit$752M$806M$1.2B$1.4B$1.9B
Gross Margin68.4%61.7%68.3%69.8%71.6%
R&D Expenses$160M$180M$205M$220M$301M
SG&A Expenses$466M$588M$735M$917M$1.2B
Operating Expenses$626M$768M$940M$1.1B$1.5B
Operating Income$126M$38M$220M$309M$474M
Operating Margin11.5%2.9%13.0%14.9%17.5%
Interest Expense$62M$36M$36M$43M$80M
Income Before Tax$20M$10M$215M$300M$340M
Tax Expense$4M$5M$8M-$118M$92M
Net Income$17M$5M$206M$418M$247M
Net Margin1.5%0.4%12.2%20.2%9.1%
EPS (Diluted)$0.25$0.07$2.94$5.78$3.48
EBITDA$140M$109M$324M$424M$587M
Shares Outstanding69M70M74M74M72M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms